The research, conducted by Rachel Giles, Chrisna Durandt, Melvin A. Ambele and Michael S. Pepper at the University of Pretoria, tackles a bottleneck that has long constrained obesity research. Most laboratory models of adipogenesis—the process by which undifferentiated cells mature into lipid-filled fat cells—rely on murine cell lines such as the immortalized 3T3-L1 preadipocyte line derived from mouse embryos. Although these models are well established, human cells offer greater physiological compatibility and relevance to human disease. The South African team therefore turned to adipose-derived stromal/stem cells, or ASCs, which are isolated from adipose tissue and possess a strong natural capacity to differentiate into adipocytes. Because these cells are of human origin, findings obtained with them are more likely to translate reliably into the clinical setting, making them an excellent platform for studying human fat cell formation in a dish.

Adipogenesis itself is a tightly choreographed biological program. Multipotent mesenchymal stromal/stem cells first commit to the preadipocyte lineage and then accumulate intracellular lipid droplets as they mature into adipocytes. Researchers typically quantify this process in two complementary ways: by measuring the accumulation of lipid droplets inside the cells, a morphological hallmark of differentiation, or by tracking the expression of genes associated with adipogenesis. Both approaches have historically been performed in large 6-well or 12-well culture plates, formats that consume substantial quantities of cells, reagents and time. Screening a library of 100 potential anti-obesity compounds in triplicate under such conditions quickly becomes prohibitively expensive, which is precisely the problem the Pretoria group set out to solve by asking whether adipogenic differentiation could be reliably monitored in much smaller wells.

To answer that question, the team isolated ASCs from adipose tissue donated by patients undergoing liposuction, with informed consent and approval from the university’s Research Ethics Committee. The cells were expanded in complete growth medium and characterized by flow cytometry, showing the expected surface marker profile: positive for CD44, CD73 and CD90, and negative for CD34, CD45 and CD105. The absence of CD105 deviates slightly from the minimal criteria recommended by the International Society for Cell and Gene Therapy and the International Federation for Adipose Therapeutics and Science, but the researchers note that CD105 expression is known to vary with culture conditions, and previous work has shown that CD105-negative mesenchymal stromal cells retain full differentiation potential across all three mesodermal lineages. Consistent with that literature, the cells in this study differentiated robustly into adipocytes when induced.

The experimental design was elegantly systematic. ASCs were seeded into 6-, 12-, 24-, 48- and 96-well plates, with plating densities adjusted to each well size, and driven to differentiate over 21 days using a cocktail of adipogenic inducers: the phosphodiesterase inhibitor IBMX, insulin, the cyclooxygenase inhibitor indomethacin and the glucocorticoid dexamethasone. Non-induced cultures served as undifferentiated controls. Lipid accumulation was then assessed on days 0, 14 and 21 using four independent readouts: fluorescence microscopy, flow cytometry, reverse transcription quantitative polymerase chain reaction (RT-qPCR) and spectrophotometry. Under the microscope, induced cultures in every well size displayed cells studded with multiple intracellular lipid droplets stained by the fluorescent dye Nile Red, while non-induced controls showed only low-level background fluorescence attributable to endogenous cellular fluorophores such as flavins and flavoproteins. By day 21, some cells harbored enlarged droplets, hinting at the droplet merging that characterizes fully mature adipocytes in living tissue.

Flow cytometry provided quantitative confirmation. The proportion of Nile Red-positive cells was highest in the standard 6-well format, reaching 41.85 percent on day 14 and 38.38 percent on day 21, but substantial differentiation was also detected in every smaller format, including roughly 30 percent of cells in the 96-well plates. Differences between days 14 and 21 were not statistically significant, and the only significant differences among plate sizes on day 14 were between the 6-well plate and the 24- and 48-well plates. Spectrophotometry, which measures the optical density of the lipid dye Oil Red O extracted from stained cells and normalized to cell count, likewise showed elevated lipid content in induced cultures across all well sizes, with no significant differences between formats on either measurement day. One technical wrinkle emerged: unbound Oil Red O tended to stick to the plastic of smaller wells, inflating optical density readings in non-induced controls as well size decreased.

The gene expression data told a similar story, with an important caveat. Induced cultures upregulated the key adipogenic transcription factors PPARG and CEBPA—PPARγ being the master regulator of fat cell formation—together with the PPARγ-responsive genes CD36 and FABP4, which mark terminally differentiated adipocytes. Expression levels were statistically indistinguishable across the 6-, 12- and 24-well formats. However, the smaller wells yielded too few cells to extract sufficient RNA consistently, forcing the researchers to pool wells for RT-qPCR and leaving the 48- and 96-well gene expression data incomplete. Low RNA yield from the smallest formats thus stands as the principal limitation for transcript-based readouts, and the authors suggest that the RT-qPCR protocol will need optimization for low cell numbers before gene expression can serve as a truly high-throughput endpoint.

To compare the different plate sizes and methods rigorously, the team employed Bland-Altman multiple comparison plots, a statistical technique that assesses agreement between measurement approaches by examining bias and the limits of agreement. Using the 6-well plate as the reference standard, the 24-well format showed the least variability for flow cytometry and for both PPARG and FABP4 gene expression, while the 96-well plate consistently showed the highest variability. When methods were compared against each other with flow cytometry as the reference, spectrophotometry produced the tightest agreement across all well sizes on both days 14 and 21. The overall conclusion was encouraging: all well sizes were broadly comparable, meaning the choice of assay can be guided by reliability and cost rather than by fundamental incompatibility between formats.

Cost analysis drove the practical payoff home. Assuming a standard 21-day induction and including positive, negative and non-induced controls in triplicate, screening 100 compounds by spectrophotometry in 48-well plates would cost approximately R30,998, or about $1,658, making it the cheapest option by a clear margin. Flow cytometry in the same format would cost roughly $2,099, while RT-qPCR in 12-well plates—the smallest format that reliably yielded sufficient mRNA—would run to about $5,223. The researchers conclude that adipogenic differentiation of human ASCs can be quantified with confidence in 24- and 48-well plates, offering a higher-throughput, more time-efficient and more affordable approach than the traditional 6-well standard. Spectrophotometry emerges as an ideal first-pass screen for anti-adipogenic activity, with flow cytometry providing rich single-cell quantification and RT-qPCR illuminating gene-level effects at later stages of a screening pipeline. The critical next step will be validating the platform with established anti-adipogenic compounds such as PPARγ antagonists, a demonstration that would cement the assay’s utility in the hunt for the next generation of obesity therapies.

Subject of Research: Development of a high-throughput in vitro assay for monitoring adipogenesis of human adipose-derived stromal/stem cells for anti-obesity drug screening

Article Title: Development of a high-throughput assay for monitoring adipogenesis in vitro

Article References: Giles, R., Durandt, C., Ambele, M. A., & Pepper, M. S. (2026). Development of a high-throughput assay for monitoring adipogenesis in vitro. Current Research in Biotechnology, Article 100419. https://doi.org/10.1016/j.crbiot.2026.100419

Image Credits: AI Generated

DOI: 10.1016/j.crbiot.2026.100419

Keywords: adipogenesis, obesity, adipose-derived stromal/stem cells, high-throughput screening, flow cytometry, spectrophotometry, RT-qPCR, Nile Red, Oil Red O, PPARG, drug discovery, cell culture

The study, published in Applied Microbiology and Biotechnology, set out to answer a question that has been asked repeatedly in the cultured meat community but seldom resolved with such systematic rigor: can sera from adult cattle, pigs, and chickens, collected as a byproduct of ordinary meat processing, support the demanding growth requirements of muscle cells destined for cultured meat? The answer, according to the research led by Da-Young Lee and corresponding author Sun Jin Hur, is a qualified but emphatic yes, provided the sera are carefully characterized and supplemented.

The investigators began by collecting blood from cattle, pigs, and chickens under protocols approved by the Animal Experiment Ethics Committee of Chung-Ang University, with approvals numbered 202401030030 and 202301020084. All animal procedures were conducted in accordance with relevant institutional and national guidelines. Because livestock serum would be derived from animals already processed for food, the approach sidesteps the most persistent ethical objection to FBS, namely its fetal origin, while also promising a supply chain that is more abundant, more traceable, and potentially far cheaper than the fetal serum market.

The first stage of the work involved comprehensive biochemical and physicochemical profiling of the sera. The researchers measured parameters that matter deeply to cell biologists: osmolality, pH, protein content, and the biochemical composition that determines whether a serum can sustain living cells. All of the livestock sera tested met sterility requirements, a crucial threshold for any candidate medium component destined for food production. Notably, however, some of the livestock sera showed deviations in physicochemical parameters relative to FBS, deviations that would later inform the optimization strategy. This finding matters because serum is not a simple solution but a complex biological cocktail of growth factors, hormones, attachment factors, carrier proteins, and lipids, and even modest differences in composition can ripple through cell behavior in culture.

With the sera characterized, the team turned to the functional heart of the study: proliferation and differentiation assays using bovine satellite cells, the muscle stem cells responsible for postnatal muscle growth and regeneration. These cells are the workhorses of cultured meat, because they are the ones that must divide vigorously to build biomass and then differentiate and fuse into the multinucleated muscle fibers that give meat its texture and protein content. The results were strikingly species-dependent. Bovine and porcine sera consistently supported robust proliferation, myogenic differentiation, and long-term expansion of the satellite cells. Chicken serum, by contrast, failed to deliver the same performance, unable to sustain the growth trajectory that bovine and porcine sera achieved. For a field that has mostly treated serum as interchangeable, this species-specific divergence is a meaningful data point, suggesting that donor species compatibility should be a central design criterion in serum substitution.

Perhaps the most demanding test was long-term serial passaging. In industrial cultured meat bioprocessing, cells cannot simply be grown once and harvested; they must be expanded repeatedly, through many rounds of passaging, to generate the enormous cell numbers required to fill bioreactors at commercial scale. Serum that supports a few days of growth is of limited value if the cells senesce or lose their myogenic potential after several passages. The optimized bovine- and porcine-based substitutes supported stable proliferation during serial passaging, indicating that the cells retained their proliferative capacity and functional identity over extended culture. This stability is precisely the property that distinguishes a laboratory curiosity from a scalable industrial input.

The optimization itself represents the technical centerpiece of the work. Raw livestock serum, while competent, did not fully match FBS in every respect, so the researchers enhanced the final formulations with targeted supplements. Two additives proved particularly effective: lipid-rich albumin and insulin-transferrin-selenium, the latter supplied at a concentration of 25 micrograms per milliliter. The logic of these supplements is grounded in cell physiology. Albumin serves as a carrier protein for fatty acids and other lipids, which muscle cells require in substantial quantities for membrane synthesis and energy metabolism but which adult serum can deliver inconsistently. Insulin provides anabolic signaling that drives glucose and amino acid uptake, transferrin supplies iron in a controlled and bioavailable form, and selenium acts as an antioxidant cofactor that protects cells from oxidative stress during rapid proliferation. Together, these supplements significantly enhanced cellular performance, closing the gap between livestock serum and FBS to the point of full functional replacement.

The economic implications may prove as consequential as the biological ones. Fetal bovine serum is one of the most expensive components of cell culture medium, with prices driven by limited supply, batch-to-batch variability, and demand from pharmaceutical and research markets that far exceed anything the cultured meat industry can command. Cost analysis conducted by the Chung-Ang University team revealed that replacing FBS with the optimized livestock-derived serum formulations reduced total medium cost by 62.6 percent. Given that medium costs are widely regarded as the single largest barrier to price parity between cultured meat and conventional meat, a reduction of this magnitude in a core medium ingredient represents a substantial step toward commercial viability. The fact that the raw material, adult livestock serum, is an abundant byproduct of existing slaughter operations adds a circular economy dimension, transforming a low-value waste stream into a high-value input.

The study does not claim that every obstacle has been cleared. The researchers note that while all sera met sterility requirements, the deviations in physicochemical parameters among some livestock sera underscore the need for standardization, since cultured meat production at scale will demand consistent, reproducible serum quality from batch to batch. The poor performance of chicken serum also illustrates that a single universal substitute may not exist, and that serum selection may need to be matched to cell line and process. Regulatory pathways for food-grade serum of slaughter origin will likewise require attention as the technology moves toward commercial deployment. Nevertheless, the demonstration that bovine and porcine sera can fully replace FBS, sustain serial passaging, and do so at dramatically reduced cost addresses the three most cited weaknesses of FBS at once: ethics, scalability, and price.

Funded through the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry via the High Value-added Food Technology Development Program under the Ministry of Agriculture, Food and Rural Affairs, the work reflects a growing national commitment to cell-based food technology. For an industry that has struggled to reconcile its sustainability narrative with its dependence on fetal calf blood, optimized slaughter livestock serum offers a resolution that is effective, scalable, and ethically aligned. If subsequent scale-up studies confirm these results in suspension culture and bioreactor settings, the humble byproduct of the slaughterhouse floor may become one of the key ingredients that finally allows cultured meat to grow up.

Subject of Research: Optimization of slaughter livestock serum as a fetal bovine serum substitute for bovine satellite cell culture in cultured meat production

Article Title: Optimization of slaughter livestock serum as an alternative to fetal bovine serum in cultured meat application

Article References: Lee, D.-Y., Mariano, E., Park, J. W., Namkung, S., Choi, S. Y., Lee, W. J., Shin, Y. W., Bok, C. H., & Hur, S. J. (2026). Optimization of slaughter livestock serum as an alternative to fetal bovine serum in cultured meat application. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-14017-3

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14017-3

Keywords: cultured meat, fetal bovine serum, livestock serum, cell culture, bovine satellite cells, myogenic differentiation, serum substitutes, bioprocessing, cell proliferation, medium cost reduction, food biotechnology, sustainable food production

The core innovation is deceptively simple. Rather than relying on invasive skin biopsies, blood draws or urine collection, the protocol uses hairs plucked with intact follicles, ideally in the anagen or growth phase, when the follicle is rich in proliferative keratinocytes. Once plucked, the hairs are placed in a kit and can be mailed over long distances without refrigeration. In the laboratory, keratinocytes are released from the follicles by trypsinization, an enzymatic digestion that separates the cells from the hair shaft, and are then cultured under conditions that preserve their proliferative capacity. The authors report that samples remain stable for days at ambient temperature, provided standard biosafety precautions are observed, which makes ordinary postal and courier services viable conduits for human biological material.

Why does the choice of starting cell matter so much? Induced pluripotent stem cells, first generated by Shinya Yamanaka and colleagues in 2007 through the forced expression of defined transcription factors, can differentiate into all three embryonic lineages, including the neural lineage that gives rise to neurons and glia. But the quality and efficiency of reprogramming depend heavily on the source cell. Dermal fibroblasts require a punch biopsy, an uncomfortable procedure that typically must be performed by a clinician. Peripheral blood mononuclear cells require venipuncture and careful handling, and although blood held at room temperature has been used successfully, the window is limited. Renal epithelial cells from urine are noninvasive but yield variable numbers of cells and are not suitable for every donor. Keratinocytes, by contrast, reprogram efficiently, and hair plucking is essentially painless.

The Yale team’s protocol lowers the technical barrier even further by requiring fewer follicles than previous hair-based approaches. Earlier methods for isolating keratinocytes from plucked hair existed, including protocols published by Aasen and colleagues in 2008 and 2010, but they generally demanded either fresh local collection or specialized handling. The new kit-based workflow explicitly anticipates the realities of remote participation: a donor, a family member or a healthcare provider can perform the collection after watching a short instructional video that accompanies the protocol, and the resulting sample tolerates the delays of long-distance shipping. This matters enormously for rare disease research, where patients are geographically dispersed and where systematic reviews have documented substantial inequities in access to clinical genetic services.

Once the keratinocytes arrive in the laboratory, the workflow follows a well-trodden but carefully optimized path. The cells are expanded in culture, with the Rho kinase inhibitor Y-27632 playing a supporting role in improving survival, a trick borrowed from the keratinocyte literature where ROCK inhibition prolongs the lifespan of adult cells in vitro. Reprogramming then converts the keratinocytes into iPS cells, a process the protocol completes within roughly two months of receiving the hair samples. Notably, the authors emphasize that the procedure requires only basic familiarity with mammalian cell culture techniques and no specialized equipment beyond what a standard cell biology laboratory already possesses. That accessibility is a deliberate design choice: the protocol is written to be executable by labs that have never worked with human iPS cells before.

Quality control is built into the workflow. The published protocol includes characterization steps confirming that the resulting iPS cells express canonical pluripotency markers, retain a normal karyotype, and can differentiate into all three germ layers, including neural lineages. The authors demonstrate the full pipeline by generating cerebral organoids, three-dimensional self-organizing cultures that recapitulate key features of early human brain development. Organoid generation from the iPS cells takes 30 to 40 days and requires one piece of specialized equipment, an orbital shaker, which keeps the growing organoids suspended and nourished in culture. Whole-mount imaging and immunostaining confirm that the organoids contain the expected neural cell populations, establishing that hair-derived iPS cells are fully competent for demanding three-dimensional differentiation protocols.

The protocol did not emerge in a vacuum. It was developed and refined in the course of a primary research study, published in Nature in 2025, in which Zhang and colleagues showed that dysregulation of mTOR signalling is a converging mechanism in lissencephaly, a severe malformation of cortical development. For that study, the team needed iPS cells and brain organoids from patients with rare neurogenetic conditions, many of whom lived far from any research center. The kit-based hair collection method proved to be the practical answer, and the new Nature Protocols article distills that hard-won experience into a form other laboratories can adopt directly. The authors acknowledge the patients and families who contributed samples, underscoring that the method was shaped by the needs of the very people it is meant to serve.

The broader implications reach into drug development, disease modeling and eventually cell therapy. Human iPS cell-derived models allow researchers to study cellular and molecular mechanisms of disease in genuinely human tissue, something animal models often fail to capture, and cerebral organoids in particular have transformed the study of neurodevelopmental disorders since Lancaster and colleagues first described them in 2013. By making the front end of that pipeline, patient sample acquisition, dramatically easier, the Yale protocol could expand the diversity of genetic backgrounds represented in organoid studies, a long-standing concern in a field where most cell lines derive from patients already connected to major academic medical centers. Populations in low-resource settings, pediatric patients for whom blood draws are difficult, and elderly donors with fragile veins all stand to benefit from a collection method that requires nothing more than a pair of tweezers and a mailing envelope.

There are, of course, practical considerations. The protocol specifies that hairs must be plucked with follicles intact, since the follicle bulb contains the keratinocyte population of interest, and the accompanying video walks collectors through identifying suitable anagen-phase hairs. Shipping times must remain within the window during which the keratinocytes stay viable at ambient temperature, and laboratories must handle all human material under appropriate biosafety procedures. Reprogramming efficiency, while generally high for keratinocytes, still varies between donors, as it does for all somatic cell sources. Yet the authors argue that the advantages outweigh these constraints: the method is noninvasive, the samples are robust, the timeline is competitive, and the equipment requirements are minimal. As personalized medicine pushes toward models built from each patient’s own genome, protocols like this one may determine who gets to participate. A technology that turns a handful of plucked hairs into a patient-specific mini brain, mailed across continents in an ordinary package, is a striking reminder that sometimes the most transformative tools in biomedicine are also the most humble.

Subject of Research: A kit-based protocol for remote collection of hair follicle keratinocytes and their reprogramming into induced pluripotent stem cells for cerebral organoid generation

Article Title: Kit-based remote collection and isolation of human reprogrammable somatic cells for generation of induced pluripotent stem cells and cerebral organoids

Article References: Cheng, I. Q., Ruiz, J. F., Casalino, E. K., Zhang, C., & Louvi, A. (2026). Kit-based remote collection and isolation of human reprogrammable somatic cells for generation of induced pluripotent stem cells and cerebral organoids. Nature Protocols. https://doi.org/10.1038/s41596-026-01440-z

Image Credits: AI Generated

DOI: 10.1038/s41596-026-01440-z

Keywords: induced pluripotent stem cells, keratinocytes, hair follicles, cerebral organoids, reprogramming, remote sample collection, disease modeling, personalized medicine, neurodevelopmental disorders, Nature Protocols, cell culture, lissencephaly

The appeal is obvious. Commercial multiwell plates are inexpensive enough at small scale, but custom formats, unusual geometries, and specialized fixtures for microscopy or mechanical testing are either unavailable or prohibitively costly. As 3D printers have proliferated in wet laboratories, researchers have increasingly printed jigs, holders, and even culture chambers on demand. The catch is that a printed object is not automatically a culture device. It must survive sterilization, remain mechanically stable, and, crucially, prove non-toxic to living cells. Those three requirements, the new work shows, do not always travel together.

The team, led by Sergio Noé and Núria Gavara of the Universitat de Barcelona with collaborators at the Universitat Politècnica de Catalunya-BarcelonaTech, focused on two of the most common 3D printing materials: Poly-Lactic Acid (PLA) filament, the workhorse of fused filament fabrication, and Acrylonitrile Butadiene Styrene (ABS)-like photopolymer resins used in vat photopolymerization. Specimens printed from each material were subjected to the three sterilization methods most familiar to cell biologists: ultraviolet light exposure, immersion in ethanol, and steam autoclaving. The researchers then interrogated the treated samples at both macroscopic and nanoscopic scales, using tensile testing to measure bulk mechanical behavior and nanoindentation to probe local stiffness and surface integrity.

The results revealed a striking material-specific pattern of vulnerability. ABS-like resin, which measured 0.31 ± 0.07 GPa in stiffness in its baseline state, remained mechanically viable after UV illumination, which actually raised its measured modulus to 1.19 ± 0.02 GPa, and after autoclaving, at 0.36 ± 0.05 GPa. Ethanol, however, proved catastrophic: submerged specimens deteriorated to a modulus of just 0.01 ± 0.00 GPa, effectively losing their structural integrity. For a material that otherwise tolerates heat and radiation, this solvent sensitivity is a decisive limitation, since ethanol immersion is one of the simplest and most ubiquitous sterilization methods in any laboratory.

Mechanical survival, however, turned out to be only half of the story. Even when ABS-printed devices were successfully sterilized by methods they could tolerate, they proved toxic to cultured cells. Switching to Formlabs Grey resin, an inert photopolymer, did not rescue the situation; the cytotoxic effect persisted. This finding carries a cautionary message for the growing community of laboratory makers: a printed device can pass every mechanical test and still quietly kill the cells it is meant to house. Residual monomers, unreacted photoinitiators, or surface chemistry introduced during printing and post-processing may leach into culture medium in ways that standard material characterization does not detect.

PLA told a different story. Untreated PLA specimens measured 1.22 ± 0.09 GPa and remained essentially unchanged after ethanol immersion, at 1.23 ± 0.15 GPa, and after UV exposure, at 1.21 ± 0.01 GPa. The autoclave, however, was its undoing: steam sterilization dropped the modulus to 0.75 ± 0.20 GPa, a substantial degradation consistent with the hydrolytic and thermal sensitivity of PLA at autoclave temperatures. Here the researchers found an elegant workaround. By switching to Heat-Treated PLA, or HTPLA, a filament that has been thermally annealed to improve its thermal and dimensional stability, the autoclave problem disappeared. HTPLA specimens retained a stiffness of 1.07 ± 0.13 GPa after autoclaving, remaining well within the range compatible with structural use in a culture device.

With a material that could survive the full sterilization arsenal in hand, the team assembled complete glass-bottomed multiwell devices and subjected them to a sequential sterilization protocol combining autoclaving, ethanol treatment, and UV illumination. The resulting platforms were then validated in the most direct way possible: by growing cells on them. Using A549 human lung epithelial cells, the researchers confirmed that the sterilized HTPLA devices supported healthy long-term culture. Cell morphologies appeared normal, and the cells proliferated with a doubling time of 21.06 ± 4.66 hours, a figure consistent with expectations for this cell line in standard culture vessels. The devices also proved compatible with immunostaining workflows, extending their utility beyond simple culture to fixed-cell imaging and molecular labeling experiments.

The combination of a glass optical bottom with a printed polymer body is central to the design’s value. Glass remains the gold standard surface for high-resolution microscopy, offering optical clarity, low autofluorescence, and well-characterized cell adhesion properties that many printed polymers cannot match. By bonding standard glass coverslips into printed well frames, the researchers created devices that behave optically like commercial glass-bottom dishes while retaining the geometric freedom of additive manufacturing. Laboratories can now print multiwells with custom well counts, spacings, or integrated features tailored to specific microscopes, assays, or experiments, and sterilize them with equipment already present in the facility.

The broader significance of the work lies in its systematic approach. Rather than assuming that any sterilization method will suit any printing material, the study provides quantitative mechanical data across a matrix of material-sterilization combinations, exposing failure modes that would otherwise be discovered the hard way, through warped devices, failed cultures, or unexplained cell death. It also demonstrates that the sterilization protocols already standard in cell biology laboratories, UV light, ethanol, and autoclaving, can be applied directly to 3D-printed materials when the material is chosen wisely. The authors frame their contribution as a set of open designs and protocols: in-house 3D-printing and assembly instructions for glass-bottomed multiwells based on HTPLA, paired with optimized sterilization sequences validated for long-term culture and immunostaining.

For laboratories weighing the cost of specialized culture formats, the message is empowering but disciplined. A few hundred euros of printer and filament can replace custom-machined or commercially unavailable devices, but only if researchers respect the material science underneath. Ethanol will destroy ABS-like resins; the autoclave will weaken standard PLA; and even a mechanically sound, sterilized resin print may still poison cells. Heat-treated PLA, processed through a deliberate sequence of autoclave, ethanol, and UV sterilization, currently offers the most reliable path from the printer bed to the incubator. As 3D printing continues its march into wet laboratories, studies like this one supply the evidence base that turns a promising workshop trick into dependable laboratory practice, allowing researchers to print, sterilize, and culture with confidence that their custom devices will protect, not compromise, the cells within.

Subject of Research: Design and sterilization of 3D-printed glass-bottomed multiwell devices for cell culture and immunostaining

Article Title: Design and sterilization of 3D-printed glass-bottomed multiwells for cell culture and immunostaining

Article References: Noé, S., Barberá-Flichi, F., Sanz-Fraile, H., Padilla, J. A., Jorba, I., Buj-Corral, I., Xuriguera, E., Jiménez-Piqué, E., & Gavara, N. (2026). Design and sterilization of 3D-printed glass-bottomed multiwells for cell culture and immunostaining. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-14032-4

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14032-4

Keywords: 3D printing, cell culture, sterilization, HTPLA, PLA, ABS-like resin, glass-bottomed multiwells, immunostaining, additive manufacturing, biomaterials, nanoindentation, autoclaving

The research, carried out by Yongjing Xie and Michael Butler at the National Institute for Bioprocessing Research and Training in Dublin and University College Dublin, tackled a stubborn problem that has plagued hydrolysate users for years. Although hydrolysates are known to boost cell growth and productivity, their molecular composition is extraordinarily complex, and no two production batches are ever quite the same. This batch-to-batch variability has made hydrolysates a risky proposition for manufacturers who must satisfy strict regulatory requirements for consistency. Worse still, the biological mechanisms underlying the beneficial effects of hydrolysates have remained poorly understood, largely because the mixtures contain thousands of molecular species that are difficult to identify individually.

To unravel this complexity, the team combined time-resolved compositional profiling with chemometric analysis, a family of statistical techniques designed to extract meaningful patterns from large, complicated datasets. Culture media were supplemented with different batches of cottonseed hydrolysates and sampled throughout the course of batch cultures lasting ten days. The molecular contents of the samples were mapped using liquid chromatography coupled to high-resolution mass spectrometry, a technique capable of separating and detecting thousands of individual compounds in a single run. Each molecular feature was labelled by its mass-to-charge ratio and retention time, creating a detailed fingerprint of every hydrolysate batch as it evolved over the life of the culture.

The biological results were striking. When CHO DG44 cells, a stably transfected cell line widely used in antibody production, were grown with cottonseed hydrolysate supplementation, the cultures lasted longer and maintained consistently high cell viability throughout the ten-day period. Interestingly, the viable cell density was actually lower than in unsupplemented control cultures, yet antibody productivity was significantly enhanced. This decoupling of cell number from productivity suggests that hydrolysates do not simply feed the cells; they fundamentally change how the cells behave, apparently directing more of their metabolic effort toward making the therapeutic protein rather than merely multiplying.

Metabolic profiling added further depth to the story. Supplementation altered the pattern of nutrient utilization in ways that reduced the accumulation of lactate and ammonia, two metabolic byproducts that are notorious for inhibiting cell growth and degrading product quality in industrial bioreactors. Lower levels of these waste products help explain the extended culture longevity observed in the hydrolysate-supplemented batches. By keeping the cellular environment cleaner, the hydrolysates appear to buy the cells additional productive time, a property that bioprocess engineers prize because longer, healthier cultures translate directly into higher yields from the same equipment.

Perhaps the most consequential finding concerned glycosylation, the process by which sugar chains are attached to antibodies after they are synthesized. Glycosylation is not a cosmetic detail; it governs how long an antibody survives in the bloodstream and how effectively it recruits immune mechanisms. The hydrolysate-based cultures produced antibodies with substantially increased galactosylation, meaning a greater proportion of the attached glycans carried terminal galactose residues. However, the degree of this increase varied between hydrolysate batches, providing the first direct evidence that batch-to-batch compositional differences in the supplement are transmitted all the way through to the quality attributes of the final medicine.

This is where the chemometric analysis proved its worth. By correlating the mass spectrometry fingerprints of each hydrolysate batch with the measured culture outcomes, the researchers identified specific molecular features, tagged by their mass-to-charge ratio and retention time, that tracked with viable cell densities and antibody production. These features now serve as candidate markers, chemical signposts that could eventually allow manufacturers to screen incoming hydrolysate lots before they ever reach a bioreactor. Rather than discovering quality problems after a costly production run fails, companies could one day predict, from a simple analytical profile, whether a given batch will enhance productivity, alter glycosylation, or fall short.

The implications for the biopharmaceutical industry are considerable. Hydrolysates are attractive precisely because they are cost-effective, derived from abundant agricultural byproducts such as cottonseed, and capable of replacing expensive purified media components. But regulatory agencies demand thorough characterization of any substance that touches the production process, and unexplained variability is a liability. By demonstrating a rigorous analytical framework that links chemical composition to biological performance, the Dublin team has effectively provided a template for qualifying hydrolysates with the same analytical rigor applied to the drugs themselves. The approach could accelerate the acceptance of hydrolysate supplements in commercial processes where they have historically been viewed with suspicion.

The study also carries broader scientific weight. It illustrates how modern omics-scale analytical chemistry, paired with multivariate statistics, can crack open systems that were previously treated as black boxes. Protein hydrolysates contain an estimated universe of peptides of varying lengths, free amino acids, vitamins, minerals, and trace organic molecules, and teasing out which components matter has long seemed hopeless. The identification of correlated molecular features does not yet pinpoint the exact bioactive compounds, but it narrows the search dramatically and establishes a causal bridge between what is in the bottle and what comes out of the bioreactor, both in terms of quantity and quality of the antibody product.

For now, the researchers describe their work as providing fundamental insight into how compositional variations of protein hydrolysates relate to CHO cell culture longevity, antibody productivity, and glycosylation. The next steps in the field will likely involve identifying the specific molecules behind the correlated features and testing whether purified versions can reproduce the benefits of the crude hydrolysate. If that succeeds, the industry may gain a new generation of chemically defined supplements that deliver the productivity advantages of hydrolysates without their notorious inconsistency. Until then, the message from this study is clear: every drop of hydrolysate is chemically unique, and that uniqueness matters, right down to the sugar molecules hanging off the medicines that millions of patients depend on. The bioreactors of the future may owe much of their performance to the careful chemical detective work exemplified by this research.

Subject of Research: Compositional variability of cottonseed protein hydrolysates and its impact on CHO cell antibody production and glycosylation

Article Title: Chemometric analysis shows compositional variability in cotton hydrolysates that impacts antibody productivity and glycosylation of CHO cells

Article References: Chemometric analysis shows compositional variability in cotton hydrolysates that impacts antibody productivity and glycosylation of CHO cells. (n.d.). https://doi.org/10.1007/s00253-026-13994-9

Image Credits: AI Generated

DOI: 10.1007/s00253-026-13994-9

Keywords: chemometrics, CHO cells, protein hydrolysates, cottonseed hydrolysate, monoclonal antibody, glycosylation, LC-HRMS, cell culture, biopharmaceutical manufacturing, batch variability, metabolism, galactosylation

The finding matters because cell expansion is one of the major cost bottlenecks in any cell-derived protein production system. Satellite cells are the stem cells responsible for repairing and building skeletal muscle, and they are the preferred starting material for cultivated meat and other cell-based protein ingredients because they naturally proliferate and then differentiate into muscle fibers. In most laboratories around the world, virtually every mammalian cell line is cultured at 37 degrees Celsius. But birds are not mammals. A healthy chicken runs markedly hotter than a human, and cells isolated from chicken embryos may therefore be operating below their evolutionary optimum when grown under the conventional mammalian regime.

To test this idea rigorously, the team isolated satellite cells from the leg muscles of 15-day-old chick embryos using an enzymatic digestion protocol with collagenase D and dispase II, followed by sequential filtration and differential plating to remove contaminating fibroblasts. Before any growth experiments began, the researchers performed chromosomal karyotype analysis on the cells, including GTG-banding, to confirm their chicken origin and to verify that neither culture temperature was inducing chromosomal abnormalities. The cells displayed the expected avian karyotype, with roughly eight to ten pairs of large macrochromosomes and the characteristic dot-like microchromosomes, and this pattern held true regardless of whether the cells had been maintained at 37 or 40 degrees Celsius. That genetic stability check is essential for any production platform, since uncontrolled chromosomal damage during long-term expansion would disqualify a cell population from food or biomedical applications.

The growth data were striking. When the researchers counted cells at 48-hour intervals across successive passages, the cultures held at 40 degrees Celsius consistently produced higher cell numbers than the 37-degree controls, with statistically significant differences appearing at passages 6, 7, 8, 10, and 11. Population doubling time, a standard metric describing how long a cell population needs to double in number, was significantly shorter at 40 degrees at multiple passages. Perhaps more importantly, the 37-degree cultures began to show signs of growth retardation and increasing variability from passage 6 onward, a pattern that suggests cellular senescence or stress accumulating over extended culture. The warmer cells, by contrast, maintained stable proliferation throughout the experiment.

Metabolic assays reinforced the picture. Using a Cell Counting Kit-8 assay, which measures the metabolic activity of living cells as a proxy for viability, the team found that cells grown at 40 degrees Celsius showed significantly higher activity both at early passage, passage 3, and at late passage, passage 9. In practical terms, this means the physiological temperature did not merely push cells through a temporary growth spurt; it appeared to sustain their health and vigor over many generations of expansion. The authors emphasized that the prolonged 40-degree exposure did not induce chronic thermal toxicity, addressing the most obvious concern about growing cells above the conventional mammalian setpoint. For bioprocess engineers, shorter doubling times combined with sustained viability translate directly into fewer days, fewer culture vessels, and lower cost per gram of cell-derived protein.

The molecular story was more nuanced. Immunofluorescence staining for paired box-7, or Pax-7, the transcription factor that defines the quiescent satellite cell state, showed a higher Pax-7 protein ratio in the 40-degree group. Yet when the researchers measured messenger RNA by quantitative PCR, Pax-7 transcript levels were significantly higher at 37 degrees, while expression of myoblast determination protein, or MyoD, the master regulator that marks the commitment to myogenic differentiation, was upregulated at 40 degrees. The authors caution that mRNA abundance and protein abundance are regulated at different biological levels and do not always correlate, so the two measurements should be read as complementary indicators of myogenic status rather than contradictory ones. Taken together, the data suggest that the warmer condition strikes a balance between cell cycle progression and differentiation, shifting cells transcriptionally toward myogenic commitment while still supporting robust proliferation.

Terminal differentiation, however, was essentially unchanged. When the researchers switched the cells to differentiation medium and assessed myogenin expression, myosin heavy chain production, and the fusion index, the percentage of nuclei incorporated into multinucleated myotubes, they found no statistically significant differences between the two temperatures. Myogenin mRNA, myogenin protein, and myosin heavy chain staining all told the same story: both temperatures could drive the cells to form mature muscle-like tissue, but they appeared to get there through different regulatory routes, one centered on Pax-7 and the other on MyoD. This is an encouraging result for producers, because it implies that switching to 40 degrees during the expansion phase does not compromise the cell’s fundamental ability to differentiate into contractile muscle material later.

The most provocative part of the study concerns nutrition. Bicinchoninic acid protein assays showed that total protein content did not differ significantly between the two temperatures, and neither differed from actual chick leg muscle tissue. But amino acid profiling with a dedicated amino acid analyzer revealed a qualitative split. Cells cultured at 37 degrees accumulated higher levels of glycine and alanine, amino acids associated with metabolic homeostasis, cellular integrity, and adaptive responses under altered growth conditions. Cells cultured at 40 degrees were significantly enriched in the branched-chain amino acids valine and isoleucine, as well as lysine. Branched-chain amino acids are the essential building blocks most directly tied to muscle protein anabolism, and they are known to activate the mTOR signaling pathway, the same nutrient-sensing pathway that previous work has linked to temperature-enhanced proliferation in avian satellite cells. In other words, the warmer culture condition not only grows cells faster but also yields a protein product with a profile skewed toward the amino acids most valued in muscle-derived food proteins.

The authors conclude that 40 degrees Celsius represents an optimal culture temperature for the efficient expansion of chick satellite cells, offering a practical, equipment-light strategy for anyone producing cell-derived protein materials. The study also fills a gap in the literature: earlier reports had shown that temperatures near the avian physiological range boost proliferation of chicken satellite cells, but those investigations largely stopped at cellular kinetics and early myogenic markers, without evaluating the nutritional quality of the end product. By integrating quantitative growth measurements, molecular validation, and full amino acid profiling in a single framework, the Korean team has provided a template for how culture conditions should be optimized not just for speed but for the biochemical character of the final ingredient. As the alternative protein market races toward projected demand of tens of millions of tons annually, such incremental process refinements, adjusting a thermostat rather than engineering a new cell line, may prove to be among the most immediately deployable tools for making cultivated protein economically competitive.

Beyond the headline findings, the study carries practical implications for how cell-culture processes are designed at scale. Incubator temperature is one of the few process parameters that costs essentially nothing to change, unlike medium formulation, scaffold materials, or genetic engineering, all of which add expense, regulatory complexity, or both. A simple thermal adjustment that shortens population doubling time compounds across every passage in an expansion pipeline, so even a modest per-passage gain can translate into substantially shorter overall production timelines when cells are grown through the ten or more passages typically required to build industrial biomass.

The amino acid results also invite a broader conversation about how cell-derived ingredients should be evaluated. Conventional nutrition science judges protein sources partly on their essential amino acid profile, and the enrichment of valine, isoleucine, and lysine at 40 degrees Celsius suggests that process conditions can shape not just how much protein is made but what kind. Lysine is of particular interest because it is frequently the limiting essential amino acid in cereal-based diets worldwide, so a production method that naturally biases cells toward lysine-rich protein could carry nutritional relevance beyond the cultivated meat sector.

Some caveats remain. The experiments were conducted in two-dimensional culture with serum-containing medium, whereas commercial production would likely rely on serum-free formulations and three-dimensional scaffolding, either of which could interact with temperature in unpredictable ways. The cells were also derived from embryos rather than from adult animals, and whether satellite cells from mature broiler chickens respond identically to the warmer regime has yet to be demonstrated. The authors likewise note that the divergence between Pax-7 protein and messenger RNA measurements underscores how much basic biology of avian myogenesis at physiological temperature still awaits mechanistic explanation.

Even so, the work strengthens a growing consensus that species-appropriate culture conditions deserve systematic attention. As cell agriculture matures, the laboratories that win on cost may be those that pay closest attention to the biology of the organism their cells came from.

Subject of Research: Effect of physiological culture temperature on proliferation, myogenic differentiation, and amino acid profile of chick satellite cells

Article Title: Physiological temperature enhances proliferative capacity and protein production characteristics of chick satellite cells

Article References: Kim, D. B., Lee, H. J., Lee, H. W., Jang, H. G., Oh, S.-H., Kim, J. H., & Lee, S. Y. (2026). Physiological temperature enhances proliferative capacity and protein production characteristics of chick satellite cells. Food Science of Animal Resources, 46(1), Article 101. https://doi.org/10.1007/s44463-026-00103-7

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00103-7

Keywords: chick satellite cells, culture temperature, cell-derived protein, cultivated meat, branched-chain amino acids, cell proliferation, myogenic differentiation, alternative protein, cell culture, Pax-7, MyoD, mTOR signaling